Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
Saved in:
| Title: | Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia. |
|---|---|
| Authors: | Ball S; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Awan FT; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Tomlinson BK; Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA., Stopczynski T; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Fischer MA; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Zhao Z; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Fedorov K; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Kishtagari A; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Mohan SR; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Ayers GD; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Byrne MT; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Tennessee Oncology, Nashville, Tennessee, USA., Savona MR; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. |
| Source: | American journal of hematology [Am J Hematol] 2026 May; Vol. 101 (5), pp. 1019-1024. Date of Electronic Publication: 2026 Mar 08. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41796974 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ball+S%22">Ball S</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Awan+FT%22">Awan FT</searchLink>; Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Tomlinson+BK%22">Tomlinson BK</searchLink>; Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Stopczynski+T%22">Stopczynski T</searchLink>; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Fischer+MA%22">Fischer MA</searchLink>; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+Z%22">Zhao Z</searchLink>; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Fedorov+K%22">Fedorov K</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Kishtagari+A%22">Kishtagari A</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Mohan+SR%22">Mohan SR</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Ayers+GD%22">Ayers GD</searchLink>; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Byrne+MT%22">Byrne MT</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Tennessee Oncology, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Savona+MR%22">Savona MR</searchLink>; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.; Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2026 May; Vol. 101 (5), pp. 1019-1024. <i>Date of Electronic Publication: </i>2026 Mar 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41796974 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ajh.70266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1019 Titles: – TitleFull: Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ball S – PersonEntity: Name: NameFull: Awan FT – PersonEntity: Name: NameFull: Tomlinson BK – PersonEntity: Name: NameFull: Stopczynski T – PersonEntity: Name: NameFull: Fischer MA – PersonEntity: Name: NameFull: Zhao Z – PersonEntity: Name: NameFull: Fedorov K – PersonEntity: Name: NameFull: Kishtagari A – PersonEntity: Name: NameFull: Mohan SR – PersonEntity: Name: NameFull: Ayers GD – PersonEntity: Name: NameFull: Byrne MT – PersonEntity: Name: NameFull: Savona MR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1096-8652 Numbering: – Type: volume Value: 101 – Type: issue Value: 5 Titles: – TitleFull: American journal of hematology Type: main |
| ResultId | 1 |
